Search

The market has turned choppy, but these three momentum stocks have room to run and catalysts to help them outperform even if the market stays soft.

Small-cap stocks are trading at historically depressed valuations, and these three look particularly attractive right now.

With 10,000 micro-cap stocks in the U.S. and Canada, it’s easy for the market to miss investments with a lot of potential. Here are three I like right now.

Micro-cap stocks are my bread and butter, and these are the 3 micro-cap stocks I like best today.

Micro-caps have recently pulled back sharply relative to the broader market and are becoming undervalued. These 3 micro-caps look particularly promising.

Peter Lynch is a stock-picking legend, and three of the biggest winners in the Magellan Fund shared this one trait.

The economic stage has been set for a new bull market, but what’s a value investor to do as growth stocks drag the indexes higher?

U.S. stocks are starting to look overvalued, so let’s look to our neighbor to the north for 3 attractive Canadian micro-cap stocks.

The much-anticipated market pullback seems to have begun this week—the S&P 500 and Nasdaq look set to snap their streak of weekly gains, with each index down about 1.5% since a week ago as of this morning.

TransMedics Group (TMDX) reported another terrific quarter after the bell yesterday that should have shares trading higher today. Revenue grew 223.7% to $31.4 million (beating by a whopping $7.8 million) while GAAP EPS of -$0.21 improved from -$0.46 in the year-ago quarter and beat by $0.11. That result caps off a year in which TransMedics grew revenue by 209% to $93.5 million.

Although cannabis stocks remain weak, recent polling from Florida, “The Sunshine State,” is improving industry sentiment and pointing to better conditions ahead.

Although he’s no longer helming the Magellan fund, Peter Lynch is continuing to execute his winning strategy investing in micro-cap stocks.

Although federal efforts to push through cannabis reforms have failed, recent Florida polls show powerful support for legalization.

On a marijuana-friendly April 20, cannabis stocks celebrated with product launches and a minor sell-off in the face of more federal disappointment.

The growing global middle class should bring immense profits to emerging market consumer companies. “Taipans,” the new tycoons, are already investing in them.

The AI infrastructure trade is as relevant as ever on Wall Street, and while it’s no CoreWeave, this smaller AI play is still benefiting mightily.